{"id":2907,"date":"2019-05-31T06:30:00","date_gmt":"2019-05-31T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/"},"modified":"2019-05-31T06:30:00","modified_gmt":"2019-05-31T06:30:00","slug":"forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/","title":{"rendered":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion"},"content":{"rendered":"<p><span>Antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) har under maj 2019 \u00f6kat med 198\u00a0000 aktier och r\u00f6ster till f\u00f6ljd av utnyttjande av teckningsoptioner inom ramen f\u00f6r bolagets incitamentsprogram 2017. Per den 31 maj 2019 finns det d\u00e4rmed sammanlagt 26\u00a0600 496 aktier och r\u00f6ster i bolaget.<\/span><\/p>\n<\/p>\n<p><span>G\u00f6teborg 31 maj 2019<br \/> Christoffer Rosenblad, CFO<br \/><\/span>XVIVO Perfusion AB (publ)<\/p>\n<div class=\"mfn-footer\">\n<p><span>F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, +1\u00a0720\u00a0616 2101, christoffer.rosenblad@xvivoperfusion.com<\/span><br \/><span>Magnus Nilsson, VD, +46 31-788 21 50, magnus.nilsson@xvivoperfusion.com<\/span><\/p>\n<p><span>F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/span><\/p>\n<p><span>Denna information \u00e4r s\u00e5dan information som XVIVO Perfusion AB (publ) \u00e4r skyldigt att offentligg\u00f6ra enligt lagen om handel med finansiella instrument. Informationen l\u00e4mnades f\u00f6r offentligg\u00f6rande klockan 8.30 den 31 maj 2019.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) har under maj 2019 \u00f6kat med 198\u00a0000 aktier och r\u00f6ster till&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2907","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-lhfi","mfn-news-tag-mfn-ca","mfn-news-tag-mfn-ca-shares"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) har under maj 2019 \u00f6kat med 198\u00a0000 aktier och r\u00f6ster till...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\\\/\",\"name\":\"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2019-05-31T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/","og_locale":"en_US","og_type":"article","og_title":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO","og_description":"Antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) har under maj 2019 \u00f6kat med 198\u00a0000 aktier och r\u00f6ster till...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/","name":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2019-05-31T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}